Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Feb;83(4):1101–1105. doi: 10.1073/pnas.83.4.1101

Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

S G Young, S J Bertics, L K Curtiss, D C Casal, J L Witztum
PMCID: PMC323019  PMID: 2419898

Abstract

Using a specific monoclonal antibody (MB19) against human apolipoprotein B (apo B), we have detected a genetic polymorphism in human low density lipoprotein (LDL). MB19 bound to LDL from different individuals in one of three distinct patterns of immunoreactivity: strong, weak, and intermediate. Scatchard analysis revealed that LDLs with strong and with weak binding patterns differed 10-fold in their affinity for MB19, but both bound the same total amount of antibody (about one mole of MB19 per mole of apo B). LDL showing the intermediate binding pattern yielded a curvilinear Scatchard plot that could be resolved into two distinct components with affinities similar to those of LDLs exhibiting only the high- or only the low-affinity binding of MB19. LDL chemical composition was similar for all three MB19 binding patterns, and the polymorphism remained after removal of LDL lipid or carbohydrate. Analysis of plasmas from 77 unrelated individuals indicated that 40% of them bound MB19 with low affinity, 23% with high affinity, and 36% with intermediate or "hybrid" affinity. Family studies showed that the three MB19 binding patterns result from codominant transmission of two common apo B alleles, each coding for an allotype with different affinity for MB19, conditionally designated here MB19(1) (high affinity) and MB19(2) (low affinity).

Full text

PDF
1101

Images in this article

1104Image
on p.1104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Dray S. Identification and genetic control of two rabbit low-density lipoprotein allotypes. Biochem Genet. 1968 Jun;2(1):25–35. doi: 10.1007/BF01458449. [DOI] [PubMed] [Google Scholar]
  2. Bütler R., Brunner E. On the genetics of the low density lipoprotein factors (Ag(c) and Ag(e). Hum Hered. 1969;19(2):174–179. doi: 10.1159/000152214. [DOI] [PubMed] [Google Scholar]
  3. Curtiss L. K., Edgington T. S. Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies. J Biol Chem. 1982 Dec 25;257(24):15213–15221. [PubMed] [Google Scholar]
  4. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  5. Goldstein J. L., Brown M. S. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res. 1984 Dec 15;25(13):1450–1461. [PubMed] [Google Scholar]
  6. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Krauss R. M., Burke D. J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982 Jan;23(1):97–104. [PubMed] [Google Scholar]
  8. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  9. Mao S. J., Patton J. G., Badimon J. J., Kottke B. A., Alley M. C., Cardin A. D. Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of 125I-labeled low-density lipoproteins by combined use of two monoclonal antibodies. Clin Chem. 1983 Nov;29(11):1890–1897. [PubMed] [Google Scholar]
  10. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  11. Patton J. G., Alley M. C., Mao S. J. Evaluation of monoclonal antibodies to human plasma low density lipoproteins. A requirement for lipids to maintain antigenic structure. J Immunol Methods. 1982 Dec 17;55(2):193–203. doi: 10.1016/0022-1759(82)90031-x. [DOI] [PubMed] [Google Scholar]
  12. Rapacz J., Elson C. E., Lalich J. J. Correlation of an immunogenetically defined lipoprotein type with aortic intimal lipidosis in swine. Exp Mol Pathol. 1977 Oct;27(2):249–261. doi: 10.1016/0014-4800(77)90034-x. [DOI] [PubMed] [Google Scholar]
  13. Schneider W. J., Kovanen P. T., Brown M. S., Goldstein J. L., Utermann G., Weber W., Havel R. J., Kotite L., Kane J. P., Innerarity T. L. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest. 1981 Oct;68(4):1075–1085. doi: 10.1172/JCI110330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Schonfeld G., Lees R. S., George P. K., Pfleger B. Assay of total plasma apolipoprotein B concentration in human subjects. J Clin Invest. 1974 May;53(5):1458–1467. doi: 10.1172/JCI107694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schumaker V. N., Robinson M. T., Curtiss L. K., Butler R., Sparkes R. S. Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism. J Biol Chem. 1984 May 25;259(10):6423–6430. [PubMed] [Google Scholar]
  16. Teng B., Thompson G. R., Sniderman A. D., Forte T. M., Krauss R. M., Kwiterovich P. O., Jr Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1983 Nov;80(21):6662–6666. doi: 10.1073/pnas.80.21.6662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Theolis R., Jr, Weech P. K., Marcel Y. L., Milne R. W. Characterization of antigenic determinants of human apolipoprotein B. Distribution on tryptic fragments of low density lipoprotein. Arteriosclerosis. 1984 Sep-Oct;4(5):498–509. doi: 10.1161/01.atv.4.5.498. [DOI] [PubMed] [Google Scholar]
  18. Tsao B. P., Curtiss L. K., Edgington T. S. Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins. J Biol Chem. 1982 Dec 25;257(24):15222–15228. [PubMed] [Google Scholar]
  19. Utermann G., Wiegandt H. Comparative studies of the Lp(a)-lipoprotein and low density lipoproteins of human serum. Hoppe Seylers Z Physiol Chem. 1971 Jul;352(7):938–946. doi: 10.1515/bchm2.1971.352.2.938. [DOI] [PubMed] [Google Scholar]
  20. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  21. Witztum J. L., Young S. G., Elam R. L., Carew T. E., Fisher M. Cholestyramine-induced changes in low density lipoprotein composition and metabolism. I. Studies in the guinea pig. J Lipid Res. 1985 Jan;26(1):92–103. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES